David Moradi has filed a Form 144 to sell 200,000 shares of AudioEye, Inc., valued at approximately $2.6 million. This filing, dated October 30, 2026, suggests a significant move by the company officer, which could have implications for both Moradi and the broader software services industry.
Background
Moradi David is a reporting owner associated with AudioEye, Inc., a company classified under the Services-Prepackaged Software sector. The recent filing is part of Moradi's ongoing disclosures regarding his holdings. AudioEye, Inc. is listed under the Central Index Key (CIK) 0001362190 and has been active in the market with various filings, including a recent Form 4 on October 2, 2026.
What the Filing Says
The filing indicates that Moradi plans to sell 200,000 Class A shares of AudioEye, Inc. The approximate market value of this transaction is reported to be $2,606,000. The shares were acquired from the public market over several transactions dating back to August 2021. Moradi's relationship to the issuer is noted as an officer of the company.
Impact
This sale may affect other shareholders and investors in AudioEye, Inc., as insider sales can influence market perceptions. The filing also notes that all shares will be sold by Sero Capital LLC, which may further attract attention from market analysts and investors.
What's Next
The filing does not say what happens next regarding Moradi's future plans or any potential impact on AudioEye, Inc.
Read Next
Platford Giles Richard to Sell 55,617 Takeda Shares
Takeda's Teresa Bitetti to Sell 46,609 Shares Amid Tax Obligations
Kiniksa Pharmaceuticals reports significant stock sale by officer
Moat Ross to Sell Over 103,000 Shares of Kiniksa Pharmaceuticals
Paolini to Sell 96,000 Shares of Kiniksa Pharmaceuticals
Kiniksa Pharmaceuticals officer sells 47,540 shares








